Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-041-4 | CAS number: 102-60-3
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity (OECD 401): LD50 = 2890 mg/kg bw (BASF 82/265; 1982)
Acute dermal toxicity (OECD 402 & GLP): LD50 > 2000 mg/kg bw (SafePharma 1691/003; 2002)
Key value for chemical safety assessment
Additional information
Acute oral toxicity:
To assess acute oral toxicity of ethylenediamine, +4PO, (BASF, 82/265, 1982) Wistar rats were dosed with 2610; 3830 and 5000 mg/kg bw test substance (vehicle: water) by gavage using the standard acute method according to OECD 401. Clinical signs observed throughout all dose groups included dyspnoe, apathy, staggering, diarhea and a bad general condition. These symptoms completely regressed max. within 1 h in males and max. within 5 h in females. All observed mortalities occured within the first 24 h after dosing. Female mortalities were observed at the lowest dose level (1/5 females; whereas male mortalities initially emerged at 3830 mg/kg bw (3/5 males). Necropsy of deceased animals confirmed the observed diarhea. Necropsy of survivors did not reveal any abnormalities. Overall, this study can be considered as reliable for assessment. Under the chosen testing conditions, ethylenediamine, +4PO showed significant acute toxicity only at higher dosages:
Oral LD50 = 2890 mg/kg bw
Acute dermal toxicity:
To assess acute dermal toxicity of ethylenediamine, +4PO, (Safe Pharm 1691/0003; 2002) Wistar rats were dosed with 2000 mg/kg bw undiluted test substance in a limit test according to OECD 402. No mortality and no signs of systemic toxicity occured. Female animals displayed erythemas at the test site. Overall, this study can be considered reliable for assessment. Under the chosen testing conditions, the test substance did not show significant acute toxicity:
Dermal LD50 > 2000 mg/kg bw
Acute inhalative toxicity:
In accordance with column 2 of REACH Annex VIII-X, in addition to the oral route, for substances other than gases, an acute toxicity study for at least one other route is required. The choice of the second route will depend on the nature of the substance and the likely route of human exposure. In the case of ethylenediamine, +4PO the dermal route was selected.
Justification for classification or non-classification
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC and 1272/2008/EEC. In conclusion, ethylenediamine, +4PO does not require classification for acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
